Skip to main content

Extracorporeal Shock-Wave Lithotripsy, Endoscopy Beneficial for Pancreatitis

Medically reviewed by Carmen Pope, BPharm. Last updated on May 28, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, May 28, 2024 -- For patients with chronic pancreatitis and intraductal stones, combined extracorporeal shock-wave lithotripsy (ESWL) and endoscopic retrograde pancreatography (ERP) provides pain relief at 12 weeks, according to a study published online May 28 in the Annals of Internal Medicine.

Rupjyoti Talukdar, M.D., from the Asian Institute of Gastroenterology in Hyderabad, India, and colleagues examined the pain-relieving effect of pancreatic duct decompression in 106 patients with chronic pancreatitis and intraductal stones. Combined ESWL and ERP were compared to sham procedures (52 and 54 patients, respectively); the primary end point was pain relief at 12 weeks.

The researchers found that the ESWL/ERP group showed better pain relief than the sham group at 12 weeks (mean difference in change, −0.7 on the visual analog scale). At the 24-week follow-up, the difference between the groups was not sustained; no differences were seen between the groups in 30 percent pain relief at 12- or 24-week follow-up. Compared with the sham group, in the ESWL/ERP group, there was an increase in the number of pain-free days (median difference, 16.2 days) and a reduction in the number of days using opioids (median difference, −5.4 days) at 12-week follow-up. The groups had similar safety outcomes.

"Compared with a sham procedure, pancreatic ductal clearance using combined ESWL/ERP provided modest short-term pain relief in patients with chronic pancreatitis and intraductal stones," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted May 2024

Read this next

Pancreatic Enzyme Therapy Linked to Drop in Pediatric Acute Pancreatitis

TUESDAY, April 16, 2024 -- Use of pancreatic enzyme therapy (PERT) is associated with a reduction in the incidence rate of acute pancreatitis (AP) among children with pancreatic...

Evidence-Based Approach Recommended for Acute Pancreatitis Management

MONDAY, March 18, 2024 -- In a clinical guideline issued by the American College of Gastroenterology and published online in the March issue of the American Journal of...

GI Adverse Events Increased With Use of GLP-1 Agonists for Weight Loss

FRIDAY, Oct. 6, 2023 -- Use of glucagon-like peptide 1 (GLP-1) receptor agonists for weight loss is associated with increased risks for pancreatitis, gastroparesis, and bowel...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.